X-LINKED AGAMMAGLOBULINEMIA AND X-LINKED IMMUNODEFICIENCY B cell development is regulated by multiple signals derived from stromal cell contact, cytokines, antigens and helper T cells. Biochemical analyses and in vivo gene targeting experiments have implicated tyrosine kinases as key regulators of many of these signaling pathways (Satterthwaite and Witte, 1996) . Bruton's tyrosine kinase (Btk) is one of the non-receptor protein tyrosine kinases involved in regulating the B cell development and function , Vetrie et al., 1993 Rawlings et al., 1993 , Thomas et al., 1993  for review see: Sideras and Smith, 1995 , Desiderio, 1997 , Conley and Cooper, 1998 Mohamed et al. 1999) . Btk is a 659 amino acid protein and belongs to a subfamily of tyrosine kinases, which also includes Itk, Tec and Bmx. Members of this family are expressed in haematopoietic cells and are all involved in signal transduction pathways activated by growth or differentiation factors. Btk contains, in addition to the Src homology domains SH2 and SH3 and a single C-terminal catalytic domain, a unique pleckstrin homology (PH) domain at the N-terminus and an adjacent proline-and cysteine-rich Tec homology domain. The biochemistry of Btk activation after B cell receptor signaling has recently been reviewed (Mohamed et al., 1999) .
Defects in the Btk protein result in the B cell differentiation defects X-linked agammaglobulinemia (XLA; Bruton's disease) in man and X-linked immunodeficiency (xid) in mice. XLA patients manifest recurrent bacterial infections due to a profound reduction of serum immunoglobulin (Ig) of all classes. They have very low B cell numbers in the peripheral blood, and those few B cells present exhibit an immature IgM high phenotype (Conley 1985; Campana et al., 1990) . If stimulated with anti-CD40 in vitro these B cells are able to proliferate and differentiate into specific Ig-producing cells (Nonoyama et al., 1998) . Plasma cells are almost completely lacking. Because the numbers of pre-B cells in the bone marrow are not significantly reduced, XLA reflects impaired developmental progression or increased cell death at the transition from pre-B to immature B cells in the bone marrow. Since the discovery of the Btk gene, a large variety of mutations, including single nucleotide substitutions, insertions and deletions, distributed over the entire Btk coding region have been characterized in 471 unrelated XLA families (Vihinen et al., 1999) . There is phenotypic heterogeneity among patients, even among patients from single XLA pedigrees (Bykowsky et al., 1996 , Holsinki-Feder et al., 1998 , Vihinen et al., 1999 .
The arrest of B cell development in XLA patients is not precisely defined and was shown to vary between patients (Campana et al., 1990) . So far, it has not been possible to correlate severity of the phenotypic presentation with the genotype. Recently developed techniques, such as single-cell PCR analysis, and a detailed characterization of cell surface markers in XLA bone marrow samples could help to investigate the role of Btk in human B cell development. However, the large genetic variety, differences in habitat or therapeutic interventions between patients might complicate these studies. Therefore, mouse models could serve as an alternative to study the role of Btk and the effect of Btk mutations in B cell development, since they exhibit a uniformly genetic background and can be kept under comparable conditions.
Since the early 1970s, an impressive amount of data has been accumulated concerning the functional defects in the CBA/N strain of mice, carrying the X-linked immunodeficiency (xid) mutation (Wicker and Scher, 1986) . Shortly after the identification of the Btk gene, it was shown that these mice have a mutation in the Btk PH domain, of the highly conserved Arg28 residue into cysteine , Thomas et al., 1993 . The xid phenotype in the mouse is less severe than XLA in humans (Table I) (de Weers et al., 1994a; Vihinen et al. 1999) . Furthermore, the analysis of mice deficient for Btk in their germline, which were generated by gene targeting, showed that the complete absence of Btk protein also results in the mild xid phenotype (Khan et al., 1995; Hendriks et al., 1996) . The molecular basis of the differences in phenotype between the two species is not well understood, although it is shown that the severity of the xid mutation is dependent on the genetic background of mice (Bona et al., 1980 , Khan et al., 1996 . Differences can partially be caused by the relative contributions of alternative pathways of B cell differentiation in a Btk-independent manner. An alternative explanation would be that there are differences in availability or functionality of Btk-relatives that may compensate for the absence of functional Btk, as expression of wild-type Btk or other Tec-family members can restore Ca 2/ fluxes in cell lines derived from XLA patients (Fluckinger et al., 1998) . In this context, the B cell receptor (BCR)-induced hydrolysis of phospholipids in XLA cell lines was found to be severely reduced, leading to a strong reduction in Ca 2/ flux, whereas xid B cells demonstrate only a two-fold reduction in phosphatidyl-inositide hydrolysis (Fluckinger et al., 1998 , Takata & Kurosaki, 1996 . T cell independent antibody responses in vivo are lacking.
5.
Normal responses to anti-CD40 stimulation in vitro.
6.
Heterozygous female carriers are normal, but have non-random X chromosome inactivation in the mature B cell population.
7.
Phenotypic heterogeneity between patients within single XLA families and between families; expression of the xid phenotype is dependent on the background ofthe mouse strain.
a. See text for details (Conley, 1985; Wicker and Scher, 1986; Sideras and Smith 1995; Kahn et al. 1995; Hendriks et al., 1996; Nonoyama et al., 1998) .
In spite of the obvious differences in severity of the phenotype, Btk appears to be a conserved key factor involved in both murine and human B cell development. Btk has been shown to be involved in the BCR signal transduction pathways in both human (De Weers et al., 1994b , Hinshelwood et al., 1995 and murine (Aoki et al., 1994 , Saouf et al., 1994 ) B cells. The genomic organization of the murine Btk gene is very homologous to-the human Btk gene and the Btk proteins share 99.3% homology . Transgenic human Btk could fully compensate for the absence of murine Btk (Drabek et al., 1997 , Dingjan et al., 1998 , Maas et al., 1997 , indicating that the essential sites for Btk interaction with other signal transduction components are conserved between human and mouse. In addition, large scale comparative sequence analysis of the human and murine Btk loci revealed clusters of sequence conservation in non-coding regions throughout the loci (Oeltjen et al., 1997) , which may play an essential role in the complex gene regulation. When human Btk was expressed under the control of the endogenous cis-acfing elements in a 340 kb or a 240 kb transgene construct, the expression pattern of transgenic Btk paralleled that of the endogenous Btk (Maas et (Hendriks et al., 1996) . Thus, XLA and xid may well involve the same stages of B cell development, but with quantitative differences between the species (Table I) .
TARGETED MUTATION OF BTK BY INSERTION OF A LACZ REPORTER
To determine the stage in B cell development at which defects in Btk become apparent, a mouse model was generated in which the Btk gene was inactivated through a targeted in-frame insertion of a l-galactosidase (lacZ) reporter (Hendriks et al., 1996) . The xid phenotype in these mice confirmed the earlier findings in Btk null-mutant mice (Khan et al., 1995; Kerner et al., 1995) (De Weers et al., 1993 , Genevier et al., 1994 , Smith et al., 1994 or in vivo using intracellular flow cytometric Btk detection (Maas et al., 1999) . Expression of the Btk gene was not restricted to the B cell lineage. In the bone marrow, the ER-MP20 high precursor cells of the monocyte lineage showed high lacZ activity, whereas the ER-MP20 medium fraction of granulocyte precursors manifested heterogeneous levels of lacZ expression (Figure 1 ). In the erythroid lineage (Ter-ll9/; ER-MP201w), lacZ activity was mainly detected in the most immature population of large erythroid precursors (Figure 1 ). This wide expression pattern of Btk suggests a role for Btk in multiple signaling pathways. Indeed, apart from its role in BCR-signaling Btk has been implicated as a mediator of signals from the interleukin 5 receptor (IL-5R), IL-6R and CD38 in B lymphocytes, the FceRI in myeloid cells, as well as the collagen receptor glycoprotein VI in platelets Smith, 1995, Wahl et al., 1997; Quek et al., 1998) . It was recently reported that Btk-deficient macrophages produce less nitric oxide than wild-type macrophages in response to a variety of stimuli (Mukhopadhyay et al., 1999) . Despite these findings, Btk is only essential in B cell development and cells from other haematopoietic lineages do not appear to be affected in XLA nor in xid (Sideras and Smith, 1995 (Maas et al., 1997 (Maas et al., , 1999 . These concerted phosphorylation events were shown to be enhanced by an E41K mutation (Glu-to-Lys) in the PH domain of Btk . The E41K Btk mutant, isolated using a retroviral random mutagenisis scheme, was able to induce transformation of NIH 3T3 fibroblast in soft agar cultures and relieved the IL-5 dependence of pro-B cell line Y16 (Li et al., 1995) . The nature of E41K transforming activity is associated with an increased membrane localization (Li et al., 1995; Varnai, et al., 1999) , thereby positioning Btk in close proximity to other signaling molecules, needed for activation.
To identify B cell signaling pathways activated by Btk in vivo we generated transgenic mice, which express an E41K human Btk mutant. When expression was driven by the CD19 promoter, B cell development was arrested within the immature IgM+IgD B cell stage in the bone marrow, irrespective of the presence or absence of the endogenous intact murine Btk gene (Maas et al., 1999 (Dingjan et al., 1998; Maas et al., 1999) .
ROLE FOR BTK IN THE INDIVIDUAL STEPS OF B CELL DEVELOPMENT
Btk is not required in pro and large pre-B cells
Several lines of evidence indicate that Btk is not critical for the assembly of the t H chain and the transition from the pro-B to the small pre-B cell stage. (1) Pre-B cells are generally present at normal numbers in XLA patients (Sideras and Smith, 1995) . (2) In heterozygous Btk +/-female mice, the absence of Btk did not result in a selective disadvantage up to the small pre-B cell stage (Hendriks et al., 1996) . (3) The xid phenotype can be corrected by transgenic expression of Btk from the pre-B cell stage onwards (Drabek et al., 1997) . (4) Pre-B cell receptor-mediated events, such as allelic exclusion and proliferation of B cell precursors that have performed a successful Ig H chain rearrangement, proceed normally in xid or XLA (Sideras and Smith, 1995) . (5) Despite high levels of E41K mutated Btk in the pro-B and pre-B stages, the CD19-hBtk E41K transgenic mice showed defects only from the immature B cell stage onwards (Maas et al., 1999) . Also when these mice were crossed on a RAG-l-deficient background, activated Btk did not signal developmental progression of pro-B lymphocytes (R.W.H., unpublished results).
Btk is critical for the transition from the pre-B
to the immature-B cell stage
The first role for Btk is evident at the transition of the small resting pre-B cell stage to the IgMlWlgD immature B cell stage (Figure 2 ). This transition is affected both in XLA patients (Conley, 1985) (Grawunder et al., 1995 (Anderson et al., 1996; Woodland et al., 1996; Solvason et al., 1998 (Goodnow, 1996) . Recently, two subpopulations within the immature B cell stage with differences in apoptosis sensitivity were described (Melamed et al., 1998 (Russel et al., 1991 , Eibel et al., 1994 , Goodnow et al., 1995 (Wicker and Scher, 1986 , Khan et al., 1995 , Hendriks et al., 1996 . As xid B cells were shown to express only low levels of the anti-apoptotic bcl-2 protein and to undergo spontaneous apoptosis more rapidly than wild-type B cells in vitro (Woodland et al., 1996) (Foy et al., 1996) . 
CONCLUDING REMARKS

